Literature DB >> 29462623

Identification of matrix metalloproteinase 9-interacting sequences in staphylococcal superantigen-like protein 5.

Katsuhiro Kohno1, Saotomo Itoh2, Akari Hanai1, Takemasa Takii3, Toshinobu Fujiwara4, Kikuo Onozaki1, Tsutomu Tsuji5, Shigeaki Hida1.   

Abstract

Staphylococcal superantigen like 5 (SSL5) is an exotoxin produced by S. aureus and has a strong inhibitory effect on MMP-9 enzymatic activity. However, the mechanism of inhibition remains unclear. We sought to identify the responsible regions of SSL5 for the interaction with MMP-9 by comparing a series of domain swap and deletion mutants of SSL5. Binding analyses revealed that SSL5 had two regions for binding to MMP-9 catalytic domain, β1-3 region (25SKELKNVTGY RYSKGGKHYL IFDKNRKFTR VQIFGK60) in N-terminal half and α4β9 region (138KELDFKLRQY LIQNFDLYKK FPKDSKIKVI MKD170) in C-terminal half. The collagen binding domain and zinc-chelating histidine residues of MMP-9 were not essential for the specific binding to SSL5. The domain swap mutants of SSL5 that conserved β1-3 but not α4β9 region inhibited the gelatinolysis by MMP-9, and the mutant of SSL7 that substituted β1-3 region to that of SSL5 acquired the binding and inhibitory activity. Furthermore, the polypeptide that harbored β1-3 region of SSL5 inhibited gelatinolysis by MMP-9. Taken together, SSL5 inhibits the MMP9 activity through binding to the catalytic domain, and the β1-3 region is responsible for the inhibition of proteolytic activity of MMP-9.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MMP-9; Staphylococcal superantigen-like protein 5

Mesh:

Substances:

Year:  2018        PMID: 29462623     DOI: 10.1016/j.bbrc.2018.02.138

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis.

Authors:  Yong Sun; Changde Wang; Chunzhu Gong
Journal:  J Orthop Surg Res       Date:  2020-04-16       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.